Physician

Dale A Presser, M.D.

According to 2025 Medicare claims, Dale Presser, M.D. (NPI: 1922062512) practices internal medicine in the Slidell-Mandeville-Covington, LA market, with the plurality of this provider's patient population coming from St. Tammany, LA. This provider's primary affiliated billing organization is CARDIOVASCULAR CLINIC OF COVINGTON, LLC (NPI: 1013302132; TIN: 473042987) and primary practice location at 70433-9254.

Presser's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 812 traditional Medicare patients, billed 5,356 HCPCS/CPT codes, and received $353,753 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 13,515 prescription claims across 1,415 beneficiaries totaling $1,810,487 in drug costs, led by Eliquis (Apixaban). DME data shows 13 claims. Open Payments data shows 45 records totaling $475,058. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $428,172 to $1,810,487. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $9,386 and ending at $10,165.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	854	4,451	$371,385
2016	873	4,375	$352,447
2017	976	4,616	$373,410
2018	897	5,120	$380,016
2019	919	6,062	$444,537
2020	879	11,309	$390,360
2021	842	11,763	$411,191
2022	832	11,054	$430,476
2023	809	9,792	$364,600
2024	812	5,356	$353,753

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	663	8,068	$428,172
2016	790	9,773	$575,469
2017	893	10,679	$650,151
2018	987	10,884	$803,264
2019	1,091	11,474	$1,060,630
2020	1,166	11,186	$1,107,097
2021	1,200	11,506	$1,255,211
2022	1,261	12,402	$1,555,398
2023	1,359	13,505	$1,855,307
2024	1,415	13,515	$1,810,487

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$318
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	28	$719
2019	N/R	N/R	N/R
2020	N/R	29	$1,006
2021	N/R	17	$527
2022	N/R	38	$1,529
2023	N/R	N/R	N/R
2024	N/R	13	$141

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	211	212	$280
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	482	495	$113
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	474	676	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	554	739	$57
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	215	220	$44

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	985	44,384	$853,706
Entresto	Sacubitril/Valsartan	310	12,916	$287,158
Repatha Sureclick	Evolocumab	263	10,614	$204,054
Xarelto	Rivaroxaban	147	7,350	$134,474
Brilinta	Ticagrelor	90	3,755	$55,229

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7038	Filter, disposable, used with positive airway pressure device	N	N/R	13	$141

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	37	$1,080	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	8	$473,977	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Dale A. Presser, M.D.?

Tedicare shows public-source Medicare data for Dale A. Presser, M.D. (NPI 1922062512), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dale A. Presser, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Dale A. Presser, M.D.?

Dale A. Presser, M.D. is linked to CARDIOVASCULAR CLINIC OF COVINGTON, LLC (billing NPI 1013302132) in the available physician profile data.

Does Dale A. Presser, M.D. have Open Payments data?

Dale A. Presser, M.D. has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.